HomeFinTechProteomics International: Raises $6M for high-tech blood test

Proteomics International: Raises $6M for high-tech blood test

Date:

TAPi Buys Mastercard’s Arcus Assets to Propel Mexico Market Entry

Strategic Acquisition Aims to Enhance Digital Payment Solutions in...

UK Tribunal Rules Visa and Mastercard Interchange Fees Breach Competition Law

Landmark decision finds payment giants’ multilateral interchange fees unlawful,...

UK Tribunal Rules Visa and Mastercard Fees Violate Competition Law

Landmark Decision Could Reshape Payment Processing Landscape Highlights: The UK...
  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Exit mobile version